Literature DB >> 8118388

Soluble normal and mutated DNA sequences from single-copy genes in human blood.

G D Sorenson1, D M Pribish, F H Valone, V A Memoli, D J Bzik, S L Yao.   

Abstract

Healthy individuals have soluble (extracellular) DNA in their blood, and increased amounts are present in cancer patients. Here we report the detection of specific sequences of the cystic fibrosis and K-ras genes in plasma DNA from normal donors by amplification with the polymerase chain reaction. In addition, mutated K-ras sequences are identified by polymerase chain reaction utilizing allele-specific primers in the plasma or serum from three patients with pancreatic carcinoma that contain mutated K-ras genes. The mutations are confirmed by direct sequencing. These results indicate that sequences of single-copy genes can be identified in normal plasma and that the sequences of mutated oncogenes can be detected and identified with allele-specific amplification by polymerase chain reaction in plasma or serum from patients with malignant tumors containing identical mutated genes. Mutated oncogenes in plasma and serum may represent tumor markers that could be useful for diagnosis, determining response to treatment, and predicting prognosis.

Entities:  

Mesh:

Year:  1994        PMID: 8118388

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  136 in total

1.  Circulating tumor DNA: a resuscitative gold mine?

Authors:  Zhaohui Huang; Bing Gu
Journal:  Ann Transl Med       Date:  2015-10

2.  Detecting hepatocellular carcinoma in blood.

Authors:  Lulu Hu; Chuan He
Journal:  Cell Res       Date:  2015-11-24       Impact factor: 25.617

Review 3.  Liquid biopsy in patients with pancreatic cancer: Circulating tumor cells and cell-free nucleic acids.

Authors:  Taisuke Imamura; Shuhei Komatsu; Daisuke Ichikawa; Tsutomu Kawaguchi; Mahito Miyamae; Wataru Okajima; Takuma Ohashi; Tomohiro Arita; Hirotaka Konishi; Atsushi Shiozaki; Ryo Morimura; Hisashi Ikoma; Kazuma Okamoto; Eigo Otsuji
Journal:  World J Gastroenterol       Date:  2016-07-07       Impact factor: 5.742

Review 4.  Genomic targets in saliva.

Authors:  Bernhard G Zimmermann; Noh Jin Park; David T Wong
Journal:  Ann N Y Acad Sci       Date:  2007-03       Impact factor: 5.691

5.  Methylation patterns in cell-free plasma DNA reflect removal of the primary tumor and drug treatment of breast cancer patients.

Authors:  Thomas E Liggett; Anatoliy A Melnikov; Jeffrey R Marks; Victor V Levenson
Journal:  Int J Cancer       Date:  2010-04-05       Impact factor: 7.396

Review 6.  Do circulating tumor cells, exosomes, and circulating tumor nucleic acids have clinical utility? A report of the association for molecular pathology.

Authors:  Bert Gold; Milena Cankovic; Larissa V Furtado; Frederick Meier; Christopher D Gocke
Journal:  J Mol Diagn       Date:  2015-05       Impact factor: 5.568

Review 7.  Circulating cell-free DNA for non-invasive cancer management.

Authors:  Caitlin M Stewart; Dana W Y Tsui
Journal:  Cancer Genet       Date:  2018-03-11

Review 8.  Blood-based tumor biomarkers in lung cancer for detection and treatment.

Authors:  Hirva Mamdani; Shahid Ahmed; Samantha Armstrong; Tony Mok; Shadia I Jalal
Journal:  Transl Lung Cancer Res       Date:  2017-12

Review 9.  Predicting Radiotherapy Responses and Treatment Outcomes Through Analysis of Circulating Tumor DNA.

Authors:  Aadel A Chaudhuri; Michael S Binkley; Evan C Osmundson; Ash A Alizadeh; Maximilian Diehn
Journal:  Semin Radiat Oncol       Date:  2015-05-15       Impact factor: 5.934

Review 10.  Emerging paradigms in arterial thrombosis.

Authors:  James W Wisler; Richard C Becker
Journal:  J Thromb Thrombolysis       Date:  2014-01       Impact factor: 2.300

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.